- Home
- CLLS vs GHI Comparison
CLLS vs GHI Comparison
Compare CLLS & GHI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CLLS
- GHI
- Stock Information
- Founded
- CLLS 1999
- GHI 1998
- Country
- CLLS France
- GHI United States
- Employees
- CLLS N/A
- GHI N/A
- Industry
- CLLS Biotechnology: Pharmaceutical Preparations
- GHI Finance: Consumer Services
- Sector
- CLLS Health Care
- GHI Finance
- Exchange
- CLLS Nasdaq
- GHI Nasdaq
- Market Cap
- CLLS 299.0M
- GHI 254.1M
- IPO Year
- CLLS 2007
- GHI N/A
- Fundamental
- Price
- CLLS $3.79
- GHI $10.27
- Analyst Decision
- CLLS Buy
- GHI Strong Buy
- Analyst Count
- CLLS 1
- GHI 4
- Target Price
- CLLS $4.00
- GHI $14.88
- AVG Volume (30 Days)
- CLLS 151.7K
- GHI 52.6K
- Earning Date
- CLLS 11-03-2025
- GHI 11-05-2025
- Dividend Yield
- CLLS N/A
- GHI 14.39%
- EPS Growth
- CLLS N/A
- GHI N/A
- EPS
- CLLS N/A
- GHI N/A
- Revenue
- CLLS $63,438,000.00
- GHI $27,326,828.00
- Revenue This Year
- CLLS N/A
- GHI $223.15
- Revenue Next Year
- CLLS $66.76
- GHI $5.11
- P/E Ratio
- CLLS N/A
- GHI N/A
- Revenue Growth
- CLLS 223.09
- GHI N/A
- 52 Week Low
- CLLS $1.10
- GHI $10.10
- 52 Week High
- CLLS $3.83
- GHI $13.94
- Technical
- Relative Strength Index (RSI)
- CLLS 65.98
- GHI 41.19
- Support Level
- CLLS $3.36
- GHI $10.10
- Resistance Level
- CLLS $3.60
- GHI $10.44
- Average True Range (ATR)
- CLLS 0.24
- GHI 0.22
- MACD
- CLLS 0.02
- GHI -0.03
- Stochastic Oscillator
- CLLS 96.95
- GHI 27.36
About CLLS Cellectis S.A.
Cellectis SA is a clinical stage biotechnological company, employing the core proprietary technologies to develop products based on gene-editing, with a portfolio of allogeneic Chimeric Antigen Receptor T-cells, or UCART, product candidates in the field of immuno-oncology and gene-edited hematopoietic stem and progenitor cells, or HSPC product candidates in other therapeutic indications.
About GHI Greystone Housing Impact Investors LP Beneficial Unit Certificates representing assignments of limited partnership interests
Greystone Housing Impact Investors LP engaged in acquiring a portfolio of mortgage revenue bonds (MRBs) that are issued by state and local housing authorities to provide construction and/or permanent financing for affordable multifamily housing, seniors housing, and commercial properties. It has four reportable segments, namely Affordable Multifamily MRB Investments, Seniors and Skilled Nursing MRB Investments, MF Properties, and Market-Rate Joint Venture Investments. It generates the majority of its revenue from the Affordable Multifamily MRB Investments segment.